← Open Payments lookup

KATHERINE WOLVERTON: Open Payments

NPI 1033851282 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$919 in 60 payments from 15 companies in 2025. Trend: 2023 $350 · 2024 $906 · 2025 $919

Food & beverage: $839Education: $80
CompanyPaymentsAmount
Sumitomo Pharma America, Inc.32$346
UROGEN PHARMA, INC.6$142
Janssen Biotech, Inc.5$138
VERTEX PHARMACEUTICALS INCORPORATED2$42
TOLMAR, INC.2$39
PFIZER INC.2$31
COLOPLAST CORP2$30
Novartis Pharmaceuticals Corporation2$29
Dendreon Pharmaceuticals LLC1$24
Boston Scientific Corporation1$20

Products named: ORGOVYX, ERLEADA, ZUSDURI, GEMTESA, XTANDI, JELMYTO, JATENZO, Luja Coude.

Industry payments across NE — which companies pay providers there.